Publications by authors named "Jeffrey Raizer"

Claim this Profile
P
Phase 1b Study of Dazostinag Plus Pembrolizumab After Hypofractionated Radiotherapy in Patients With Select Advanced Solid Tumors.
Benjamin T Cooper, Wade T Iams, David B Page, Yuan Yuan, Naamit K Gerber, Jeffrey Raizer

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design.
Rupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, Can Ilgın, Manmeet S Ahluwalia, Jeffrey Raizer

Neuro Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible downregulation of HLA class I in adenoid cystic carcinoma.
Annie Li, Bianca L Gonda, Elizabeth M Codd, Adam von Paternos, Dawn R Mitchell, Jeffrey Raizer

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Joe S Mendez, Adam L Cohen, Midori Eckenstein, Randy L Jensen, Lindsay M Burt, Jeffrey Raizer

Neurooncol Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy.
Karan Dixit, Lauren Singer, Sean Aaron Grimm, Rimas V Lukas, Margaret A Schwartz, Jeffrey J Raizer

Cancers (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.
Samuel J Klempner, Keun-Wook Lee, Kohei Shitara, Jean-Phillippe Metges, Sara Lonardi, Jeffrey J Raizer

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pudexacianinium (ASP5354) chloride for ureter visualization in participants undergoing laparoscopic, minimally invasive colorectal surgery.
Matthew Albert, Leticia Delgado-Herrera, Jennifer Paruch, Pauline Gerritsen-van Schieveen, Tomoyoshi Kishimoto, Jeffrey Raizer

Surg Endosc· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma.
Kohei Shitara, Akihito Kawazoe, Akihiro Hirakawa, Yuka Nakanishi, Satomi Furuki, Jeffrey Raizer

Cancer Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.
Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee, Jeffrey J Raizer

Neuro Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.
Christina I Tsien, Stephanie L Pugh, Adam P Dicker, Jeffrey J Raizer, Martha M Matuszak

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.
Priya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, Marc C Chamberlain, David Schiff, Jeffrey J Raizer

Neurooncol Adv· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
Andrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, Miguel J Gil-Gil, Vinay K Puduvalli, Jeffrey J Raizer

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
Karan S Dixit, Sean Sachdev, Christina Amidei, Priya Kumthekar, Tim J Kruser, Jeffrey J Raizer

J Neurooncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.
Kurt A Jaeckle, Karla V Ballman, Martin van den Bent, Caterina Giannini, Evanthia Galanis, Jeffrey J Raizer

Neuro Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Vinay K Puduvalli, Jing Wu, Ying Yuan, Terri S Armstrong, Elizabeth Vera, Jeffrey Raizer

Neuro Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
Erik Ladomersky, Lijie Zhai, Kristen L Lauing, April Bell, Jiahui Xu, Jeffrey J Raizer

Clin Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
Rachna Malani, Martin Fleisher, Priya Kumthekar, Xuling Lin, Antonio Omuro, Jeffrey Raizer

J Neurooncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study.
Mark Rosenthal, Paul M Clement, Mario Campone, Miguel J Gil-Gil, John DeGroot, Jeffrey Raizer

ESMO Open· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Eudocia Q Lee, Peixin Zhang, Patrick Y Wen, Elizabeth R Gerstner, David A Reardon, Jeffrey J Raizer

Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma Patients.
Jakob T Lupa, Jeffrey J Raizer, Irene B Helenowski, Benjamin P Liu, Kartik Kesavabhotla

Front Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
Michael R Drumm, Karan S Dixit, Sean Grimm, Priya Kumthekar, Rimas V Lukas, Jeffrey J Raizer

Neuro Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, Andrew M Silverman, Luis Aparicio, Jeffrey Raizer

Nat Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines.
Susan M Chang, Hans Messersmith, Manmeet Ahluwalia, David Andrews, Priscilla K Brastianos, Jeffrey Raizer

J Clin Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, Andrew M Silverman, Luis Aparicio, Jeffrey Raizer

Nat Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines.
Susan M Chang, Hans Messersmith, Manmeet Ahluwalia, David Andrews, Priscilla K Brastianos, Jeffrey Raizer

Neuro Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis